Am J Physiol Endocrinol Metab 279:E956E962 Ahlkvist L, Brown K, Ahrn B (2013) Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion
Inform adult patients with type 2 diabetes mellitus on an insulin secretagogue (e.g., sulfonylurea) or insulin that they may have an increased risk of hypoglycemia when using SAXENDA and to report signs and/or symptoms of hypoglycemia to their healthcare provider [see Warnings and Precautions (5.4)]
If you are unsure what else to add to your routine, we recommend using our online tool to get personalized suggestions based on your specific health goals
If youve been curious about GLP-1 medications like semaglutide or tirzepatide but hesitant because of side effects, rigid protocols, or a one-size-fits-all approach Flow Wellness is redefining what GLP-1 therapy can look like
Bring your symptom log Discuss whether dose reduction or pause is appropriate Discuss whether anxiety treatment (therapy, medication) is appropriate Step 5: Treat anxiety as a separate condition if needed
Oral supplements are widely available and often more accessible than injections